Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Cefuroxime axetil
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cefuroxime 250mg tablets
0501021K0AAABAB
|
Cefuroxime axetil | Cefuroxime axetil | Infections | 676 |
|
Cefuroxime 125mg/5ml oral suspension
0501021K0AAACAC
|
Cefuroxime axetil | Cefuroxime axetil | Infections | 61 |
|
Cefuroxime 125mg tablets
0501021K0AAAAAA
|
Cefuroxime axetil | Cefuroxime axetil | Infections | 49 |
|
Zinnat 250mg tablets
0501021K0BBABAB
|
Zinnat | Cefuroxime axetil | Infections | 19 |
|
Zinnat 125mg tablets
0501021K0BBAAAA
|
Zinnat | Cefuroxime axetil | Infections | 2 |
|
Zinnat 125mg/5ml oral suspension
0501021K0BBACAC
|
Zinnat | Cefuroxime axetil | Infections | 2 |
|
Cefuroxime 125mg granules for oral suspension sachets
0501021K0AAADAD
|
Cefuroxime axetil | Cefuroxime axetil | Infections | No data available |
|
Zinnat Suspension 125mg granules sachets
0501021K0BBADAD
|
Zinnat | Cefuroxime axetil | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.